These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chemotherapy in the post-MVAC era: the case for adjuvant chemotherapy. Lehmann J, Retz M, Stöckle M. World J Urol; 2002 Aug; 20(3):144-50. PubMed ID: 12196897 [Abstract] [Full Text] [Related]
4. Paclitaxel in the treatment of advanced urothelial cancer. Bajorin DF. Oncology (Williston Park); 2000 Jan; 14(1):43-52, 57; discussion 58, 61-2. PubMed ID: 10680149 [Abstract] [Full Text] [Related]
5. Cisplatin, ifosfamide, methotrexate and vinblastine combination chemotherapy for metastatic urothelial cancer. Kyriakakis Z, Dimopoulos MA, Kostakopoulos A, Karayiannis A, Sofras F, Zervas A, Giannopoulos A, Dimopoulos C. J Urol; 1997 Aug; 158(2):408-11. PubMed ID: 9224313 [Abstract] [Full Text] [Related]
6. Review and outlook for the role of paclitaxel in urothelial carcinoma. Vaughn DJ. Semin Oncol; 1999 Feb; 26(1 Suppl 2):117-22. PubMed ID: 10190793 [Abstract] [Full Text] [Related]
7. Systemic chemotherapy in locally advanced and/or metastatic bladder cancer. Pectasides D, Pectasides M, Economopoulos T. Cancer Treat Rev; 2006 Oct; 32(6):456-70. PubMed ID: 16935429 [Abstract] [Full Text] [Related]
8. Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline. Segal R, Winquist E, Lukka H, Chin JL, Brundage M, Markman BR, Cancer Care Ontario Practice Guidelines Initiative Genitourinary Cancer Disease Site Group. Can J Urol; 2002 Oct; 9(5):1625-33. PubMed ID: 12431323 [Abstract] [Full Text] [Related]
9. Update on chemotherapy for advanced bladder cancer. Rosenberg JE, Carroll PR, Small EJ. J Urol; 2005 Jul; 174(1):14-20. PubMed ID: 15947569 [Abstract] [Full Text] [Related]
10. [Place of chemotherapy in the treatment of invasive bladder tumors]. Pariente JL, Theodore C, Davin JL, Rischmann P, Chopin D. Prog Urol; 1999 Apr; 9(2):219-24. PubMed ID: 10370944 [Abstract] [Full Text] [Related]
11. Chemotherapy agents in transitional cell carcinoma: the old and the new. Maluf FC, Bajorin DF. Semin Urol Oncol; 2001 Feb; 19(1):2-8. PubMed ID: 11246730 [Abstract] [Full Text] [Related]
12. Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer. Lehmann J, Franzaring L, Thüroff J, Wellek S, Stöckle M. BJU Int; 2006 Jan; 97(1):42-7. PubMed ID: 16336326 [Abstract] [Full Text] [Related]
14. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma. Edelman MJ, Meyers FJ, Houston J, Lauder I. Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226 [Abstract] [Full Text] [Related]
15. Medical therapy of advanced malignant epithelial tumours of the ovary. Colombo N, Parma G, Bocciolone L, Franchi D, Sideri M, Maggioni A. Forum (Genova); 2000 Oct; 10(4):323-32. PubMed ID: 11535983 [Abstract] [Full Text] [Related]
17. Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer. Muramaki M, Miyake H, Kurahashi T, Takenaka A, Inoue TA, Fujisawa M. Int J Urol; 2008 Apr; 15(4):314-8. PubMed ID: 18380818 [Abstract] [Full Text] [Related]
19. Progress in the chemotherapy of metastatic cancer of the urinary tract. Raghavan D. Cancer; 2003 Apr 15; 97(8 Suppl):2050-5. PubMed ID: 12673696 [Abstract] [Full Text] [Related]
20. Chemotherapy for metastatic bladder cancer. Kantoff PW, Scher HI. Hematol Oncol Clin North Am; 1992 Feb 15; 6(1):195-203. PubMed ID: 1556050 [Abstract] [Full Text] [Related] Page: [Next] [New Search]